| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Gensemer Thomas Edward | Chief Strategy Officer | 800 NORTH CAPITOL STREET, NW, SUITE 800, WASHINGTON | /s/ Dale Proctor (Dale Proctor, Attorney-in-Fact for Thomas Edward Gensemer) | 27 Jan 2026 | 0002095722 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| holding | PPHC | Common Stock, $0.001 par value | 66,732 | 27 Jan 2026 | Direct |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| holding | PPHC | Options | 27 Jan 2026 | Common Stock, $0.001 par value | 20,000 | $12.00 | Direct | F1, F2 |
| Id | Content |
|---|---|
| F1 | The options granted on May 17, 2022 vested 100% on the third anniversary of the grant date. |
| F2 | The exercise price of the options granted on May 17, 2022 was GBP 8.85, or approximately $12.00 based on a GBP to USD exchange rate as of January 23, 2026 of 1.3564. |